244 related articles for article (PubMed ID: 11781626)
1. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
4. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
Xue L; Rui JZ; Zhang Y; Miao LY
Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus clearance is age-dependent within the pediatric population.
Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
[TBL] [Abstract][Full Text] [Related]
7. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Cutler C; Kim HT; Hochberg E; Ho V; Alyea E; Lee SJ; Fisher DC; Miklos D; Levin J; Sonis S; Soiffer RJ; Antin JH
Biol Blood Marrow Transplant; 2004 May; 10(5):328-36. PubMed ID: 15111932
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
[TBL] [Abstract][Full Text] [Related]
11. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
12. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
[TBL] [Abstract][Full Text] [Related]
13. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
[TBL] [Abstract][Full Text] [Related]
15. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
Minematsu T; Sugiyama E; Kusama M; Hori S; Yamada Y; Ohtani H; Sawada Y; Sato H; Takayama T; Sugawara Y; Makuuchi M; Iga T
Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
[TBL] [Abstract][Full Text] [Related]
17. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
18. Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation.
Lee JH; Choi SJ; Lee JH; Kim SE; Seol M; Lee YS; Lee JS; Kim WK; Lee KH
Bone Marrow Transplant; 2005 Jan; 35(1):63-9. PubMed ID: 15502852
[TBL] [Abstract][Full Text] [Related]
19. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Uberti JP; Ayash L; Braun T; Reynolds C; Silver S; Ratanatharathorn V
Bone Marrow Transplant; 2004 Sep; 34(5):425-31. PubMed ID: 15273705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
